Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

2,285 public trials 413 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Active, Not Recruiting

MAGE-A4ᶜ¹º³²T for Multi-Tumor

NCT03132922

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +67 more
Locations
  • University of Miami Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer

NCT03682068

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +10 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Bakersfield, California, United States
  • Research Site Fullerton, California, United States
  • Research Site Los Angeles, California, United States
View all 222 locations
View Trial Details
Active, Not Recruiting

Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

NCT06225596

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • University of Miami - Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Mount Sinai Medical Center of Florida, Inc. Miami Beach, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 102 locations
View Trial Details
Active, Not Recruiting

BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants

NCT05943106

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site San Diego, California, United States
  • Research Site Lakewood, Colorado, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial

NCT04216290

Conditions
Bladder Urothelial Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
View all 216 locations
View Trial Details
Active, Not Recruiting

A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

NCT06238479

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +72 more
Locations
  • AdventHealth Orlando Orlando, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 28 locations
View Trial Details

Related conditions